2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies

Overview of attention for article published in Journal of Hematology & Oncology, May 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

patent: 1 patent

Citations

dimensions_citation: 128 Dimensions

Readers on

mendeley: 126 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 128 publications that cite this research output.

128

The most recent citing publications are shown below. View all 128 publications that cite this research output on Dimensions.

Novel and multiple targets for chimeric antigen receptor-based therapies in lymphoma

Article in Frontiers in Oncology (April 2024)

Recent Advances in Material Technology for Leukemia Treatments

Article in Advanced Materials (March 2024)

Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances

Article in Journal of Controlled Release (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.